Global Market Watch:
Human Biobanking market is expected to reach US$37.1 billion 2020 primarily supported by application; Stem Cells, Blood and Blood Products, Research and Pharmaceuticals…etc. Among the Human Biobanking Application market, Advance Application is the fastest growing market with a CAGR of 9.65%. Organs and Research application in human banking together accounts approximately for 24% of the market share. Stem Cells, Blood and Blood Products, Research market with a positive growth rate during the period. Human Biobanking Industry is playing an increasing role in development of therapies and diagnosis of diseases with well-maintained researchers and institutions.
The report “Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:
· Emerging market trends
· Advancements in the technological space
· Market demand of the segments (by-region)
· Key growth areas and market size
· Key competitor’s Edge
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
The analysis primarily deals with human biobanking applications market. Further, the subdivided categories include:
1. Stem Cells
2. Blood1 & Blood Products
4. Advanced Applications
c. Drug Discovery
1. Red Blood Cells, Plasma and Platelets
2. Tissue Sections, Liver, Eyes, Kidney, Brain, Heart and Other
3. DNA, RNA, Protein Extraction, Molecular Derivatives, Cell Cultures, Microarrays, Cytogenetics, etc.
4. Body Fluids (Synovial, Urine, Sputum, Buccal Scrapings and Sperm), Contract Services and Process Chemicals
The period considered for the human biobanking applications market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia- Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 1250 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 157 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.